News Focus
News Focus
icon url

georgebailey

01/12/23 3:13 PM

#558870 RE: skitahoe #558865

Hi Gary like your thoughts and yes, plausible.
icon url

dedugan

01/12/23 3:16 PM

#558871 RE: skitahoe #558865

"...suggest that Institution's they're friendly with will help move the share price..." Umm, isn't that illegal, and basically the same (except opposite) of what we're suing them for?
Bullish
Bullish
icon url

Poor Man -

01/12/23 3:16 PM

#558872 RE: skitahoe #558865

Gary, NWBO might be the first biotech in history with a successful phase three trial that can’t close a partnership because of a printer jam and/or someone — Same person in charge of audio/visual? — forgetting to replace the ink cartridge in printer.

As we would say in Russia about this mystery — it’s a printer wrapped in a scanner wrapped in a phone fax wrapped in a ditto machine.
icon url

HyGro

01/12/23 5:06 PM

#558934 RE: skitahoe #558865

There are over 700 biotechs and trade sources say only about 2.5% have any deal in year -- that's a low probability of a biotech having a deal and certainly not an OTC biotech penny stock. Haven't found a single OTC biotech penny stock doing a BP deal in the last decade. So if a BP deal is a NWBO investment thesis, the odds say it is highly unlikely.

OTC penny stock companies with 12 years of accounting irregularities sanctioned by the SEC, is insolvent, in numerous litigations (including shareholder class action suit), who's Phase 3 trial publication has been challenged by other peer-reviewed article (Neuro-Oncology Journal) are unlikely to pass any BP due diligence.